ARTICLE | Company News
NeoTherapeutics, Johnson Matthey plc deal
September 10, 2001 7:00 AM UTC
NEOT subsidiary NeoOncoRx Inc. acquired worldwide rights to develop and market JMAT's satraplatin, a platinum anti-cancer compound (JM-216). NEOT expects to begin Phase III testing of the compound in...